Quality of life of ovarian cancer patients treated with combined platinum taxane chemotherapy: a systematic review of the literature-Reference-Cited by-同舟云学术

Quality of life of ovarian cancer patients treated with combined platinum taxane chemotherapy: a systematic review of the literature

Published:2022-04-23 Issue:9 Volume:30 Page:7147-7157
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Pergialiotis Vasilios^ORCID,Sotiropoulou Ioanna Myrto,Liatsou Efstathia,Liontos Michalis,Frountzas Maximos,Thomakos Nikolaos,Rodolakis Alexandros,Haidopoulos Dimitrios

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-022-07053-y.pdf

Reference33 articles.

1. Bezjak A, Tu D, Bacon M, Osoba D, Zee B, Stuart G, Roy JA, Piccart M, Eisenhauer E (2004) Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study. J Clin Oncol 22:4595–4603. https://doi.org/10.1200/jco.2004.08.080

2. Bhat G, Karakasis K, Oza AM (2020) Measuring quality of life in ovarian cancer clinical trials – can we improve objectivity and cross trial comparisons? Cancers (Basel) 12.https://doi.org/10.3390/cancers12113296

3. Bhugwandass CS, Pijnenborg JM, Pijlman B, Ezendam NP (2016) Effect of chemotherapy on health-related quality of life among early-stage ovarian cancer survivors: a study from the population-based PROFILES registry. Curr Oncol 23:e556–e562. https://doi.org/10.3747/co.23.3243

4. Blagden SP, Cook AD, Poole C, Howells L, McNeish IA, Dean A, Kim JW, O’Donnell DM, Hook J, James EC, White IR, Perren T, Lord R, Dark G, Earl HM, Hall M, Kaplan R, Ledermann JA, Clamp AR (2020) Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial. Lancet Oncol 21:969–977. https://doi.org/10.1016/s1470-2045(20)30218-7

5. Brotto L, Brundage M, Hoskins P, Vergote I, Cervantes A, Casado HA, Poveda A, Eisenhauer E, Tu D (2016) Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life. Support Care Cancer 24:1241–1249. https://doi.org/10.1007/s00520-015-2873-8

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis, treatment and burden in advanced ovarian cancer: a UK real-world survey of healthcare professionals and patients;Future Oncology;2024-09-04

2. Interpretable machine learning model based on clinical factors for predicting muscle radiodensity loss after treatment in ovarian cancer;Supportive Care in Cancer;2024-07-24

3. Quality of Life for Polish Women with Ovarian Cancer during First-Line Chemotherapy;Healthcare;2023-09-21

4. Association of malignant ascites with systemic inflammation and muscle loss after treatment in advanced‐stage ovarian cancer;Journal of Cachexia, Sarcopenia and Muscle;2023-07-28

5. Quality of life in women with ovarian cancer during first-line chemotherapy concerning the age of the patients;2023-05-09